ADRC News

The Wisconsin Alzheimer's Disease Research Center gratefully recognizes, along with the nation, that February is the traditional Black History Month celebration to acknowledge the contributions of African Americans to the United States of America.

Researchers from the University of Wisconsin–Madison and Wisconsin Alzheimer’s Disease Research Center (ADRC) recently presented at the 15th Annual Edition of the Human Amyloid Imaging (HAI) conference.

The Wisconsin Alzheimer’s Disease Research Center (ADRC) is pleased to announce three Developmental Projects awardees, selected for their research targeting Alzheimer’s disease and related dementias.

Nathaniel Chin, MD, joined host Rob Ferrett on the call-in program “Central Time” on The Ideas Network of Wisconsin Public Radio.

Cynthia Carlsson, MD, MS, was recently interviewed by CBS 58 News in Milwaukee about the U.S. Food and Drug Administration (FDA) approval of Leqembi (lecanemab), which showed a reduction of clinical decline in a study of people with early Alzheimer’s disease.

On January 6, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease. Leqembi is the second of a new category of medications approved for Alzheimer’s disease that target the fundamental pathophysiology of the disease.

Sanjay Asthana, MD, professor, and Duncan G. and Lottie H. Ballantine Chair, Geriatrics and Gerontology, has been invited by the US Secretary of Health and Human Services and the Director of the National Institutes of Health (NIH) to serve a four-year appointment on the National Advisory Council on Aging.

In 2022, 'Dementia Matters' released 31 episodes about Alzheimer's disease research advances, caregiver strategies and prevention tips from local and national dementia experts. Listed here are the five most popular 'Dementia Matters' episodes of 2022.

Ozioma Okonkwo, PhD, has been appointed to participate in a National Institute on Aging Alzheimer’s (NIA) and Alzheimer’s Association workgroup, establishing the definition and classification of Alzheimer’s disease.

Indigenous people living in Wisconsin and throughout the nation experience significant health and financial burden from Alzheimer’s disease and related dementias, according to new research published by a University of Wisconsin–Madison team and collaborators.